Personalis

$32.51
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.68 (+5.45%) Today

$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Personalis and other stocks, options, and ETFs commission-free!

About PSNL

Personalis, Inc. engages in the provision of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in 2011 and is headquartered in Menlo Park, CA. The listed name for PSNL is Personalis, Inc. Common Stock.

CEO

John S. West

Employees

182

Headquarters

Menlo Park, California

Founded

2011

Market Cap

1.49B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

1.11M

High Today

$33.82

Low Today

$31.61

Open Price

$31.69

Volume

1.01M

52 Week High

$53.46

52 Week Low

$4.27

Analyst Ratings

78%

of 9 ratings

Buy

78%

Hold

22%

Sell

PSNL Earnings

-$0.89

-$0.66

-$0.44

-$0.21

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

-$0.29 per share

Actual

-$0.34 per share

Replay Earnings Call